Iradimed (IRMD) Cash & Equivalents Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -36.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.99% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.52% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.25% |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 9.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.64% |
| Dec 31, 2025 | -4.08% |
| Sep 30, 2025 | 0.56% |
| Jun 30, 2025 | 0.53% |
| Mar 31, 2025 | -0.08% |
| Dec 31, 2024 | -5.55% |
| Sep 30, 2024 | -3.95% |
| Jun 30, 2024 | -4.18% |
| Mar 31, 2024 | -3.87% |
| Dec 31, 2023 | -0.20% |
| Sep 30, 2023 | -0.57% |
| Jun 30, 2023 | 0.27% |
| Mar 31, 2023 | -1.41% |
| Dec 31, 2022 | 10.05% |
| Sep 30, 2022 | 12.89% |
| Jun 30, 2022 | 17.17% |
| Mar 31, 2022 | 19.33% |
| Dec 31, 2021 | 30.30% |
| Sep 30, 2021 | 35.05% |
| Jun 30, 2021 | 37.26% |
| Mar 31, 2021 | 36.23% |
| Dec 31, 2020 | 40.10% |
| Sep 30, 2020 | 37.21% |
| Jun 30, 2020 | 39.35% |
| Mar 31, 2020 | 36.74% |
| Dec 31, 2019 | 34.90% |
| Sep 30, 2019 | 34.15% |
| Jun 30, 2019 | 39.03% |
| Mar 31, 2019 | 24.16% |
| Dec 31, 2018 | 13.11% |
| Sep 30, 2018 | 15.13% |
| Jun 30, 2018 | 19.73% |
| Mar 31, 2018 | 23.09% |
| Dec 31, 2017 | 24.41% |
| Sep 30, 2017 | 0.54% |
| Jun 30, 2017 | 57.98% |
| Mar 31, 2017 | 81.73% |
| Dec 31, 2016 | 93.06% |
| Sep 30, 2016 | 98.60% |
| Jun 30, 2016 | 77.36% |